Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $78.33, with a high estimate of $82.00 and a low estimate of $67.00. Marking an increase of 2 ...

Q2 2025 Earnings Call Transcript August 13, 2025 ARS Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $ ...

Through the power of strategic, well-built partnerships, CVS Health helps employees earn degrees — and at no cost to them.

Joshua Fredell, Pharm.D., senior vice president at CVS Caremark and PBMI Innovator Award winner, is calling for a PBM industry focus on making pharmacy experiences more seamless while continuing to ...

CVS Caremark owes the State of West Virginia $1.4 million in civil penalties after the state’s insurance commissioner found ...

O'Reilly Automotive Inc. is suing the three major pharmacy benefit managers in the U.S., as well as the three major insulin manufacturers.

While competitors continue to struggle with healthcare costs, Aetna and CVS are celebrating an 8.4% increase in ...

CVS Health said it plans to allocate $20 billion over the next decade to streamline the US health system. The initiative aims ...

CVS Health reports Q2 earnings decline due to litigation charges but boost adjusted EPS guidance, highlighting transformation and growth in healthcare services.

Aetna saw its medical benefits ratio increase months after CVS announced it would exit the ACA individual market due to struggling performance.

But overall, we would not be surprised to see CVS continue in that pattern of leverage-increasing acquisitions, deleveraging by constraining other capital-allocation activities, hitting its leverage ...